Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma
NCT07657273
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
NRT6003 Injection
Sponsor
Second Affiliated Hospital of Guangzhou Medical University